Moderna Receives Nearly $600 Million To Accelerate Development Of mRNA Bird Flu Vaccine
The U.S. government is investing nearly $600 million in Moderna to expedite the development of an mRNA vaccine for bird flu. Discover how this funding...
The U.S. government is investing nearly $600 million in Moderna to expedite the development of an mRNA vaccine for bird flu. Discover how this funding...
Moderna's RSV vaccine trial for infants has been halted amid serious safety concerns after five hospitalized cases. What does this mean for future pediatric vaccine...